SarahDAtkinsonMD

Psychiatry • Rochester, NY

Child & Adolescent Psychiatry

Physician

Join to view full profile

Dr. Atkinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Atkinson's full profile

Already have an account?

Office
885 Winton Rd S
Rochester, NY 14618
Phone+1 585-241-9670

Fax+1 585-241-3243
Is this information wrong?

Education & Training

Menninger School of PsychiatryFellowship, Child and Adolescent Psychiatry, 1992 - 1994
University of Oklahoma Health Sciences CenterResidency, Psychiatry, 1989 - 1992
University of Oklahoma Health Sciences CenterResidency, Surgery, 1987 - 1989
University of Oklahoma College of MedicineClass of 1987

Certifications & Licensure

NY State Medical License 1995 - 2025
OK State Medical License 1988 - 1992
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01
Completed
Phase 3
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
Completed
Phase 3
PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01
Completed
Phase 3
Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) Start of enrollment: 2013 Oct 01
Completed
Phase 2
Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
Completed
Phase 3
Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01
Completed
Phase 3
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Start of enrollment: 2019 Oct 04
Completed
Phase 2
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® Start of enrollment: 2014 Jun 01
Recruiting
Phase 2, Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies.
Bryan Dirks, Maurizio Fava, Sarah D Atkinson, Mark Joyce, Michael E Thase, Becky Howell, Tim Lin, Serge Stankovic> ;Psychopharmacology Bulletin. 2022 Oct 27
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Mo...
Sarah Atkinson, Mary Bachinsky, Yaron Raiter, Paula Abreu, Claudia Ianos, Phillip Chappell, Robert L Findling> ;Journal of Child and Adolescent Psychopharmacology. 2022 Oct 1
83 citations
Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.
Gerard Sanacora, Michael R Johnson, Arif Khan, Sarah Atkinson, Robert R Riesenberg, Juan P Schronen, Michael A Burke, John Zajecka, Luis Barra, Hong-Lin Su, Joel A. Po...> ;Neuropsychopharmacology. 2017 Mar 1
35 citations
A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
Atkinson, S. D., Prakash, A., Zhang, Q., Pangallo, B. A., Bangs, M. E., Emslie, G. J., March, J. S.> ;Journal of child and adolescent psychopharmacology. 2014 May 13
2 citations
Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A...
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, Fahua She, Todd Leathers, Sanjeev Pathak> ;Psychopharmacology Bulletin. 2011 May 15
26 citations
Hypoalbuminemia may predispose infants to necrotizing enterocolitis.
Sarah D. Atkinson, David W. Tuggle, William P. Tunell> ;Journal of Pediatric Surgery. 1989 Jul 1
29 citations
Clinical characteristics, pathophysiology, and management of hydrocarbon ingestion: case report and review of the literature.
Edward J. Truemper, Santiago Reyes De La Rocha, Sarah D. Atkinson> ;Pediatric Emergency Care. 1987 Sep 1
Join now to see all

Hospital Affiliations

Rochester General HospitalRochester, New York